Get started

Editas Medicine, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

EDIT chart

Key stats

Market capitalization
877.175MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.71USD
Net income
−220.432MUSD
Revenue
19.712MUSD
Shares float
81.049M
Beta
2.29

About Editas Medicine, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Gilmore O’Neill
Website
editasmedicine.com
Headquarters
Cambridge
Employees (FY)
226
Founded
2013
ISIN
US28106W1036
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Ideas

EDITAS bottoming in process, turnaround soon, target min ~22 USDEDITAS could be in the bottoming process, I am watching it for a few years now. We have a falling broadening wedge, on which we had a breakout already. This is part of a bigger falling wedge (blue). It is techincally possible, we had put in the lows at 6.35 as a wave 5 (as an ending diagonal), wh
Long
by tommtajlor
Edit Another support hold here 13.13. No price below these levels here personally I love this company and think they are going to do big things. This is a long term trade and great entry price. Of course you still have to manage risk which would mean closing weekly body below 13.13 could signal downside
by Erictaylor
1
Edit Finally may have bottomed. I played this W idea buying that flat lower support of this descending triangle target 23$ And if this is a bull flag we could be creating has support at 18.46 with resiatnce combined with descending downward line at 19.11 Seems W pattern neckline is 19.89. If we pop
Long
by Erictaylor
1
Edit End of the year for edit seems extremely positive. Results and further company plans will be out to the public. Working on cure for blindness as well as positive tumor shrinking results. This company should be massive but as of now in debt and extremely speculative. Hence the volatility. Is 25$ a
by Erictaylor
5
Editas set for a homerunEditas looks ready to launch on the weekly with a bounce off support and 3x rsi hidden bullish divergence. The full extension of this triangle using the 1.618 gives us 213 dollars as the final take profit. I dont know whats going on fundamentally with this company, but in terms of the technicals:
Long
by holmes.michael.p
is it time?This one is a Sleeping giant! There is so much indications to go long on this bad boy. EDIT is a true sleeper but when it moves get ready to hit the gears on full throttle. We are seeing tons of accumulation on the TTM indicator it is only a matter of time before the squeeze goes into play. Earnings
Long
by miguelsique

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers